ZHEJIANG SYNCOZYMES BIO-PHARMACEUTICAL CO LTD

Overview

ZHEJIANG SYNCOZYMES BIO-PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering BUPROPION HYDROCHLORIDE; QUETIAPINE FUMARATE; ß-NICOTINAMIDE ADENINE DINUCLEOTIDE.

API / Drug Master Files

ZHEJIANG SYNCOZYMES BIO-PHARMACEUTICAL CO LTD holds 3 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ß-NICOTINAMIDE ADENINE DINUCLEOTIDEActive2026-01-13
• BUPROPION HYDROCHLORIDEActive2025-06-17
• QUETIAPINE FUMARATEActive2024-06-07

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to ZHEJIANG SYNCOZYMES BIO-PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.